Investigations into the physiological control and mode of action of the mammalian hexokinases have been hampered somewhat by the absence of efficient procedures for their purification. Until this year only hexokinase type I from brain (Schwartz & Basford, 1967; Chou &Wilson, 1972) and pig heart (Easterby & OBrien, 1973) had been purified to homogeneity. The key to these procedures was the particulate nature of the type I isoenzyme in the tissues, which allowed its relatively selective extraction, thus easing the purification load. We have added to this list by reporting the isolation to homogeneity of rat hepatic glucokinase (hexokinase, type IV) (Holroyde & Trayer, 1974; Holroyde et al., 1976a,b) . The crucial step in this procedure was affinity chromatography on a SepharoseN-(6-am~nohexanoyl)-2-amino-2-d~xy-~-g~ucop~anose matrix. Our earlier reports on the use of this matrix (Chesher et al., 1973) indicated that whereas glucokinase bound selectively and reversibly to this matrix, low-K,,, hexokinase activity in the liver extracts (presumably a mixture of types I, I1 and 111) and yeast hexokinase apparently passed through the column unretarded. This was puzzling, since it was known that both glucosamine and N-acetylglucosamine were good inhibitors of all four isoenzymes with respect to glucose (Walker, 1966) . In addition, the observation that the Sepharose conjugate of this aminohexanoic acid derivative of glucosamine could be used to purify hexokinase type I1 from rat skeletal muscle prompted us to investigate this affinity-chromatography step further.
In this communication we report on the synthesis of a variety of N-aminoacyl-glucosamine derivatives, their kinetic behaviour as inhibitors of the hexokinase reaction and how this information can be used to design affinity-chromatography systems which are 'tailor-made' for each particular hexokinase isoenzyme. The various glucosamine derivatives described below (N-aminopropionyl-, N-aminobutyryl-and N-amino-octanoylglucosarnine) were all synthesized by the same method as for the N-aminohexanoyl derivative (Barkeretal., 1974; Holroydeetal., 1976~) . The kinetic and initial chromatography experiments were performed with hexokinase isoenzymes partially purified on DEAEcellulose as described by Grossbard & Schimke (1966) until they were homogeneous with respect to hexokinase type when stained for activity on agarose-gel electrophoresis . Hexokinase type I was obtained from rat kidney, type IT from rat muscle and type 111 and glucokinase from rat liver. They were assayed as previously described (Holroyde et al., 1976c1,b) .
All of the N-aminoacyl-glucosamine derivatives proved to be competitive inhibitors with respect to glucose of the rat and yeast hexokinase isoenzymes, but with differing K, values. In fact, a direct correlation was found to exist between these kinetic data and the effectiveness of a particular derivative as an affinity-chromatographic medium when 565th MEETING, STIRLING immobilized on Sepharose. The Kl values of yeast hexokinase for all these derivatives ranged from 8 m~ to over 2 4 m (the longer the aminoacyl 'arm', the higher the Ki) and so it was not surprising that this enzyme did not interact significantly with the corresponding Sepharose conjugates.
The only really effective inhibitor for the rat kidney hexokinase type I was the Namino-octanoyl derivative (K1 = 1.3 mM) and only the Sepharose conjugate of this derivative proved to be a suitable affinity matrix. This isoenzyme was probably responsible for our initial observations of low-K,,, hexokinase activity appearing in the washthrough fraction when liver extracts were applied directly to the SepharoseN-aminohexanoylglucosamine matrix (Chesher et ul., 1973) . Subsequent chromatography experiments showed that provided that the K1 for the ligand in free solution was G 2 m~ then a suitable atlinity matrix could be constructed. Further, in situations where the KI of two isoenzymes for a particular ligand differed (but were both less than 2mM) these enzymes could be separated chromatographically either by adjusting the ligand concentration attached to the gel or by using a glucose gradient for elution. For example, hexokinase type I1 (Kl = 0 . 4~) and glucokinase (K, = 0.75m) could be separated on a Sepharose-N-aminohexanoylglucosamine conjugate in this way. It should be pointed out that attachment of either glucosamine or the various amino acids directly to CNBractivated Sepharose did not provide matrices that showed any significant interaction with the isoenzymes. Although these pilot experiments were carried out on a small scale, it was possible to handle large quantities of tissue extracts in this way. Consequently, in conjunction with conventional methods, it was possible to purify hexokinase types I and 111 from the kidneys and livers, respectively, of 50 rats on a Sepharose-N-aminooctanoylglucosamine matrix.
Thus, by varying either the length of the 'spacer' arm or the concentration of ligand attached to Sepharose a glucosamine affinity matrix has been designed specifically for each mammalian hexokinase. These results also suggest that, at least in this case, the 'spacer' arm appears to be making a specific contribution to the enzyme-immobilized-
